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Background: Atherosclerosis—a major cause of vascular
disease, including ischemic heart disease (IHD), is a pathology
that has a two-fold higher mortality rate in the Azorean Islands
compared to mainland Portugal.
Aim: This cross-sectional study investigated the role of genetic
variation in the prevalence of atherosclerosis in this
population.
Subjects and methods: A total of 305 individuals were
characterized for polymorphisms in eight susceptibility genes
for atherosclerosis: ACE, PAI1, NOS3, LTA, FGB, ITGB3, PON1
and APOE. Data were analysed with respect to phenotypic
characteristics such as blood pressure, lipid profile, life-style
risk factors and familial history of myocardial infarction.
Results: In the total sample, frequencies for
hypercholestrolemic, hypertensive and obese individuals were
63.6%, 39.3% and 23.3%, respectively. The genetic profile was
similar to that observed in other European populations,
namely in mainland Portugal. No over-representation of risk
alleles was evidenced in this sample.
Conclusions: One has to consider the possibility of an
important non-genetic influence on the high cholesterolemia
present in the Azorean population. Since diet is the most
important life-style risk factor for dyslipidemia, studies aiming
to evaluate the dietary characteristics of this population and
its impact on serum lipid levels will be of major importance.
Keywords: Polymorphisms, susceptibility genes,
atherosclerosis, ischemic heart disease, Azores
INTRODUCTION
Atherosclerosis (AT), the major cause of cardiovascular
disease, including Ischemic Heart Disease (IHD), is a multi-
factoral pathological process where inflammation and
oxidative processes are key components from fatty streak
formation to plaque rupture and thrombosis (Roy et al.
2009). The death rate due to IHD is about twice as high in
the Azores Archipelago as in mainland Portugal (Direcc¸a˜o-
Geral da Sau´de 2009). However, the extent of the
contribution of genetic risk factors to this prevalence
remains unstudied. We developed a cross-sectional study of
risk factors for AT, including characterization of the
polymorphisms in a series of established susceptibility
genes for AT, namely ACE—angiotensin converting enzyme
(Rigat et al. 1990; Samani et al. 1996; Sabbagh et al. 2007),
PAI1—plasminogen activator inhibitor 1 (Onalan et al.
2008), NOS3—nitric oxide synthase (Casas et al. 2004),
LTA—lymphotoxin a (Schreyer et al. 2002; Trompet et al.
2008), FGB—fibrinogen b (Renner et al. 2002; Gialeraki
et al. 2008), ITGB3—integrin b-3 (Marian et al. 1996;
Ridker et al. 1997; Knowles et al. 2007), PON1—
paraoxonase 1 (Mackness et al. 1998; Salonen et al. 1999;
Garce´s et al. 2008) and APOE—apolipoprotein E (Burman
et al. 2009).
These genes are mainly involved in physiological
processes which have been shown to be related to
endothelial dysfunction (NOS3), inflammation (LTA),
dyslipidemia (APOE and PON1), dysfunctional coagulation
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and fibrinolysis (PAI1, FGB and ITGB3), as well as blood
pressure deregulation (ACE and NOS3), all of which can
ultimately be involved in the atherogenic process (Roy et al.
2009).
The Azores Archipelago (Portugal) is a group of nine
islands, with an area of 2344 Km2 and a total population of
237 315 (INE 2006). According to historical records, these
islands were uninhabited until the 15th century, when the
first settlers arrived, mostly from mainland Portugal and the
island of Madeira. However, people of different origins, such
as Spanish, French, Italian, English, German and Flemish
were also among the early settlers (Matos 1989; Mendonc¸a
1996). There is clear evidence that Jews also contributed to
the peopling of the archipelago and the presence of African
and Moorish slaves in the islands is also documented (Matos
1989; Mendonc¸a 1996). Research conducted in the Azorean
populations, using various types of genetic system, has
shown considerable levels of diversity (Santos et al. 2003;
2009; Montiel et al. 2005); given the particular character-
istics of the population size and composition of the Azores,
genetic studies have been conducted for several diseases (see,
for example, Bruges-Armas et al. 2002; Lima et al. 2005).
To gain insights into the determinants of atherosclerosis
in the Azorean population we analysed variation in the
previously listed loci, in a large sample of individuals of
Azorean background and related it to specific phenotypic
characteristics, such as blood pressure and serum lipid
profile. Furthermore, other individual and life-style derived
risk factors for AT were also analysed.
MATERIALS AND METHODS
Sampling
After informed consent, a total of 305 apparently healthy
unrelated individuals were sampled by collecting peripheral
blood and buccal swabs. Individuals filled in a genealogical
questionnaire, which confirmed their Azorean ancestry. The
samples were from the islands of Sa˜o Miguel (n ¼ 224),
Graciosa (n ¼ 64) and Flores (n ¼ 17).
For all participants, data concerning age, gender, height,
weight, systolic and diastolic blood pressure (BP) were
registered. Body mass index (BMI) was calculated.
Individuals were considered hypertensive if they presented
an average systolic BP of $ 140 mm Hg and/or diastolic BP
of$ 90 mm Hg (Chobanian et al. 2003) and/or if they were
taking anti-hypertensive medication. Serum total choles-
terol (TC), HDL cholesterol (HDL-C) and triglycerides
(TG) were determined by collaborating laboratories, using
standardized protocols. LDL cholesterol (LDL-C) concen-
tration was calculated by the Friedewald formula (Friede-
wald et al. 1972). Individuals were considered
hypercholesterolemic if presenting at least one of the
following situations: (a) total fasting cholesterol concen-
tration of $ 200 mg/dl; (b) LDL-C concentration of $130
mg/dl and (c) use of cholesterol-lowering medication.
Individuals were hypertriglyceridemic if triglycerides levels
were $ 150 mg/dl and/or if they were being medicated for
this alteration (Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults 2001).
Information was collected on life-style habits such as
smoking. Subjects were considered smokers if they smoked
or had stopped smoking in the last year. The presence of
family history of myocardial infarction was considered
whenever at least one-first-degree relative had a myocardial
infarction.
Genotyping
DNA was extracted from buccal swabs using JETQUICK
Tissue DNA SPIN Kit and from blood samples using
JETQUICK Blood & Cell Culture DNA SPIN Kit, for
Genomic DNA (GENOMED), according to the manufac-
turer’s specifications. Samples were genotyped by the
Spanish National Genotyping Centre (CeGen) for seven
polymorphic positions at the following candidate genes for
AT: ACE (rs1799752), PAI1 (rs1799889), NOS3 (rs1799983),
LTA (rs1041981), FGB (rs1800790) and ITGB3 (rs5918).
Polymorphisms at the PON1 (rs854560) and APOE
(rs429358; rs7412) loci were genotyped by PCR-RFLP, at
CIRN’s laboratories (University of the Azores), in
accordance with Zhang et al. (2006) and Bettencourt et al.
(2006), respectively.
Statistical analysis
Allele and genotype frequencies were estimated for all loci.
Hardy-Weinberg equilibrium (HWE) was tested using an
exact test, based on a Markov chain approach. An unbiased
estimate of heterozygosity was computed according to Nei
(1978). The statistical significance of the variance com-
ponents of the AMOVA (considering the island as the main
group) and the paired comparisons were determined by
non-parametric procedures. Pairwise population differen-
tiation exact tests, using allele frequencies, were carried out
to compare the data obtained for the three islands. Allele
frequencies for the total sample (n ¼ 305) were compared
with the available data for other European and non-
European populations. Data from mainland Portugal were
taken from David et al. (2004), Ferrer-Antunes et al. (1998),
Magro et al. (2003), Medeiros et al. (2002), Mendonc¸a et al.
(2008) and Rodrigues et al. (2005). For the remaining
populations the data used in the differentiation tests were
taken from the ALlele FREquency Database (http://alfred.
med.yale.edu/alfred), SNPedia (http://www.snpedia.com),
Entrez SNP database (http://www.ncbi.nlm.nih.gov/SNP).
All population analyses were performed using Arlequin
software version 3.0 (Excoffier et al. 2005).
A one-way between-groups multivariate analysis of
covariance was conducted to compare lipid profile in
accordance with APOE and PON1 55 genotypes with
p-values adjusted for age (42.6), gender and BMI (27.4). To
relate lipid profile with APOE genotype the sample was
reduced to 262 individuals, since those taking lipid lowering
medication were excluded from this analysis; genotypes
12*14 (n ¼ 7) and 14*14 (n ¼ 1) were also excluded due to
the small group size. Analysis for PON1 55 vs lipid profile
included a sample of 269 subjects, since individuals taking
medication for dyslipidemia were excluded. Statistical
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analyses were conducted using SPSS 15.0 software (SPSS
Inc., Chicago, IL). Due to the abnormal distribution of
blood pressure values, a kernel non-parametric regression
test was performed using the software XLSTAT version 2010
(Addinsoft 2010) to estimate the conditional expectation of
ACE/NOS3 genotype vs systolic and diastolic blood
pressure, using additional parameters (sex, age, BMI,
smoking status, myocardial infarction status, levels of TC,
LDL-C, HDL-C, TG (mg/dL). Individuals taking anti-
hypertensive medication were excluded from the previous
analysis.
In all of the analyses a p-value lower than 0.05 was
considered statistically significant.
RESULTS
Individual and life-style risk factors of AT
One hundred and sixty-seven of the 305 samples genotyped
in this study related to women (54.7%) and 138 to men
(45.3%), with a mean age of 44 ^ 11 years. The distribution
of risk factors for the studied Azorean sample, stratified by
gender and age, is shown in Table I. The total hypertensive
individuals in the Azorean sample is 39.3% and the mean
values for blood pressure are 129 ^ 25 mm Hg for systolic
BP and 78 ^ 25 mm Hg for diastolic BP. Hypertension
frequency displays a similar distribution between men and
women (26.0% and 20.0% for men and women,
respectively), in the first age group (#44 years). In the
older age group (.44 years), the percentage of men with
hypertension doubles (53.8%) and that of women triples
(59.8%), maintaining the similar differences between
genders. The total hypercholestrolemic individuals in this
sample is 63.6%, the mean value of TC being 208 ^ 50
mg/dL and the mean value for LDL-C being 127 ^ 35
mg/dL. In the first age group (#44 years), approximately
half the population (49.4% women and 52.1% men) is
hypercholesterolemic, these values rise with age, reaching in
the .44 years old group 76.8% for women and 78.5% for
men.
The individuals with hypertriglyceridemia represent ,
30% of this population, for both gender and age groups;
mean TG value is 119 ^ 66 mg/dL.
The total individuals with obesity are 23.3% for this
population and the average value of BMI is 27 ^ 5. Neither
underweight nor morbidly obese individuals are present in
men. The percentage of individuals with normal weight
decreases with age in both genders; furthermore, the
amount of overweight men increases by 1.6-fold (becoming
58.5%). In the first age group (#44 years), obesity presents
very similar values for men and women (23.4% and 23.1%
for men and women, respectively). Age has a strong impact
on obesity frequency in women, almost doubling its value
(45.2%); men maintain a similar value (23%). Concerning
smoking habits, in the #44 age group twice as many men,
compared to women, were smokers (31.5% and 15.3% of
smokers, respectively). Age stratification shows no impact
on the smoking habits of men, but is substantial in women
at age .44 years, decreasing by 76%. Family history of
infarction presented similar values for both genders and age
groups.
Population analysis of AT susceptibility loci
Since no differences were detected between samples from the
three islands, we pooled the data and used it as a single
Azorean sample. Corroborating the results from the
differentiation tests, AMOVA showed that genetic variation
within populations was significantly higher than that
observed among populations (99.7% and 0.3%, respect-
ively), providing no evidence of significant genetic
differences between the islands. Allele and genotype
frequencies for all analysed markers are presented in
Table II. All loci were in conformity with Hardy-Weinberg
equilibrium expectations. The levels of expected hetero-
zygosity are similar to those reported for other European
populations, with the highest value being registered for
PAI1 (51.52%) and the lowest for APOE (22.10%).
When comparing the allele frequencies obtained for the
present sample with those available for mainland Portugal
samples (relative to loci ACE, PAI1, NOS3, FGB, PON1 and
APOE) no significant differences were observed. For the
analysed polymorphism at the PON1, although the most
frequent allele in the Azorean sample is the 55-M allele as
opposed to mainland Portugal, where the 55-L allele is the
most frequent, the differentiation test between the
populations for this locus did not reach statistical
significance ( p ¼ 0.116).
Table I. Characterization of the Azorean population in study for several
atherosclerosis risk factors.
# 44 years þ45 years
C
(n ¼ 85)
F
(n ¼ 73)
C
(n ¼ 82)
F
(n ¼ 65)
% % % %
Hypertension
No 80.0 68.5 39.0 43.1
Yes 20.0 26.0 59.8 53.8
Not determined 0 5.5 1.2 3.1
Hypercholesterolemia
No 50.6 47.9 23.2 21.5
Yes 49.4 52.1 76.8 78.5
Hypertriglyceridemia
No 77.7 68.5 69.5 63.1
Yes 22.3 31.5 30.5 36.9
BMI
,18.5 Underweight 2.4 0 0 0
18.5–24.9 Normal 43.5 41.0 17.0 18.5
25.0–29.9 Overweight 30.6 35.6 37.8 58.5
30.0–34.9 Obese 16.5 22.0 29.3 20.0
35.0–39.9 Severely obese 5.8 1.4 12.2 3.0
.40 Morbidly obese 1.2 0 3.7 0
Smoking
No 83.5 63.0 94.0 66.2
Yes 15.3 31.5 3.6 30.7
Not determined 1.2 5.5 2.4 3.1
Family history of infarction
No 56.5 65.7 51.2 67.7
Yes 34.1 23.3 39.0 27.7
Did not know 9.4 11.0 9.8 4.6
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The only differences to a European population were
observed with the Spanish sample, for the ITGB3
polymorphism ( p ¼ 0.0107). Furthermore, the exact test
of population differentiation revealed significant differences
between the Azores and samples from the following non-
European populations: the Japanese (ACE, p ¼ 0.0000),
sub-Saharan Africans (LTA, p ¼ 0.0039; NOS3, p ¼ 0.0000)
and African-Americans (LTA, p ¼ 0.0001; PAI1, p ¼ 0.0002;
NOS3, p ¼ 0.0001; FGB, p ¼ 0.0030).
Genotype/phenotype correlations
The results of the analysis between APOE and PON1 55
genotypes and lipid profile are shown in Table III. A
statistically significant difference was observed between
LDL-C values in the three APOE genotypes. Individuals with
the 13*14 genotype had significantly higher LDL-C values
(220 ^ 7 mg/dl) than the individuals with the 13*13
(207 ^ 4 mg/dl) and 12*13 (198 ^ 8 mg/dl) genotype. No
significant effect of the APOE genotypes on triglycerides, TC
and HDL-C levels was detected.
For PON1, individuals with the 55-LL genotype had
significantly higher levels of TC (226 ^ 7 mg/dl) than
individuals with the 55-ML genotype (202 ^ 4 mg/dl). No
significant differences were observed between triglycerides,
LDL-C and HDL-C levels among PON1 genotypes.
The kernel regression test showed a slight correlation
between genotype and blood pressure (both for ACE I/D
gene polymorphism and NOS3 894G . T gene polymorph-
ism). R 2 was 0.0252 (systolic BP) and 0.0259 (diastolic BP)
for ACE and 0.0073 (systolic BP) and 0.0147 (diastolic BP)
for NOS3. Therefore, the probability of blood pressure
depending on ACE genotype is 2.52% for systolic BP and
2.59% for diastolic BP. For the NOS3 locus, the probability is
0.73% and 1.47% for systolic BP and diastolic BP,
respectively.
DISCUSSION
We have genotyped eight polymorphisms in established
susceptibility genes for atherosclerosis in 305 Azorean
samples. The genetic profile disclosed was similar to that
observed in other European populations, namely on the
mainland of Portugal. No over-representation of the
respective risk alleles at the loci studied was shown in our
sample.
Results from this study indicate that serum total
cholesterol is a major risk factor for atherosclerosis in the
Azorean population, followed by hypertension and obesity.
The BMI value found in this study, although high, has been
previously reported for other Portuguese populations
(Mendonc¸a et al. 2008). These latter authors, studying a
sample from mainland Portugal, found a mean value of BMI
(27.4 ^ 4.1) which is very similar to the result obtained for
the Azorean sample. Interestingly, the frequency of
hypercholesterolemia reported by Mendonc¸a et al. (2008)
(30.3%) is much lower than the one in the present sample
(63.6%). The high frequency of hypercholesterolemic
individuals in the Azorean population clearly sets the
background for an increased pre-disposition for athero-
sclerosis. Since we failed to detect any increased frequency of
the risk alleles in the loci putatively associated with serum
cholesterol compared with the Portuguese population, the
genetic basis for the observed tendency for hypercholester-
olemia remains to be identified.
Table II. Allele and genotype frequencies of the polymorphisms for the
seven genes for atherosclerosis among 305 Azorean.
Risk factors Position Allele % Genotype %
ACE intron 16 D 61.5 DD 39.0
I 38.5 DI 44.9
II 16.1
PAI1 2 675 5G 49.2 5G/5G 21.0
4G . 5G 4G 50.8 5G/4G 56.4
4G/4G 22.6
NOS3 894 G . T G 60.0 GG 35.4
T 40.0 GT 49.2
TT 15.4
LTA 804 C . A C 73.4 CC 54.8
A 26.6 CA 37.4
AA 7.8
FBG 2 455 G . A G 79.0 GG 61.0
A 21.0 GA 36.0
AA 3.0
ITGB3 176 T . C T 79.7 TT 63.9
C 20.3 TC 31.5
CC 4.6
PON1 55 L . M L 46.2 LL 16.7
M 53.8 ML 59.0
MM 24.3
APOE 471 T . C 12 7.0 12*12 0.0
609 C . T 13 83.0 12*13 11.8
14 10.0 12*14 2.3
13*13 68.5
13*14 17.1
14*14 0.3
Table III. Plasma lipid profile according to APOE and PON1 genotypes more represented in Azores population (mean ^ SE).a
APOE genotypes PON1 genotypes
12*13 13*13 13*14 MM ML LL
Variable (n ¼ 36) (n ¼ 180) (n ¼ 46) (n ¼ 67) (n ¼ 156) (n ¼ 46) Multiple comparison p-value
CT (mg/dl) 198 ^ 8 207 ^ 4 220 ^ 7 209 ^ 6 202 ^ 4 226 ^ 7 ML – LL 0.008
LDL-C (mg/dl) 117 ^ 6 126 ^ 2 142 ^ 5 133 ^ 4 123 ^ 3 135 ^ 5 12*13 – 13*14 0.011
13*13 – 13*14 0.035
HDL-C (mg/dl) 57 ^ 3 57 ^ 1 53 ^ 2 54 ^ 2 56 ^ 1 57 ^ 2 ns
TG (mg/dl) 119 ^ 11 155 ^ 5 135 ^ 9 122 ^ 8 121 ^ 5 121 ^ 9 ns
CT, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high- density lipoprotein cholesterol; TG, triglycerides; – , two groups are
different; Adjustments for multiple comparisons: Bonferroni; ns, non-significant ( p . 0.05). a Concentrations adjusted for age, sex and BMI.
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It is noteworthy that the frequency of family history of
infarction reported in Mendonc¸a et al. (2008) is almost half
the value (17.4%) presented in this work. The presence of a
higher familial aggregation for infarction in the Azorean
population could either reflect the shared environmental
factors or variation in loci other than those analysed in this
study. The possibility that familial forms of hypercholester-
olemia could explain, at least in part, some of this
aggregation is currently being investigated.
Numerous studies (see among others, Sing and Davignon
1985; Hanis et al. 1991; Howard et al. 1998) have previously
reported associations between variation at the APOE locus
and cholesterolemia, which we were able to confirm in the
present study. Thus, the e2 allele lowers the concentration of
TC and LDL-C levels and the e4 allele raises them. The e2
cholesterol-lowering effect is 2 – 3-times that of e4
cholesterol-raising effect. In several studies, e4 carriers
have been associated with an increased risk of coronary
heart disease (Eichner et al. 2002). On the other hand, e2
carriage may confer cardioprotective effects (Bennet et al.
2007). A correlation has previously been reported between
blood pressure and variation at ACE (Henskens et al. 2003;
Di Pasquale et al. 2004) and NOS3 (Jia et al. 2003; Sawada
et al. 2008); in accordance with these findings a slight
correlation between genotypes in the previous loci and BP
was reported in the Azorean correlation.
In conclusion, the fact that no over-representation of the
respective risk alleles at the loci studied was evidenced in our
sample does not preclude the possibility that variation at
other loci could influence the pre-disposition for athero-
sclerosis in the Azorean population. Given the fact that AT is
a multi-factoral disorder, with several genetic and
environmental factors involved, we have to consider the
possibility that an important non-genetic influence is
playing a role in the high cholesterolemia present in the
Azorean population. Diet is the most important life-style
risk factor for dyslipidemia; studies to evaluate the dietary
characteristics of this population are currently ongoing.
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